890839-31-3 Usage
Uses
Used in Organic Synthesis:
2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid is utilized as a building block in organic synthesis for its ability to participate in various chemical reactions, contributing to the creation of diverse organic compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid serves as a key component in drug development. Its unique structure allows it to be a part of the synthesis of potential therapeutic agents.
Used in Suzuki-Miyaura Cross-Coupling Reactions:
2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid is employed as a reactant in Suzuki-Miyaura cross-coupling reactions, a widely used method in organic chemistry for the formation of carbon-carbon bonds, particularly useful in the synthesis of complex organic molecules and biologically active compounds.
Used in Chemical Industry:
Its stability and reactivity make 2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid a valuable intermediate in the production of specialty chemicals, including those used in materials science and other advanced applications.
Check Digit Verification of cas no
The CAS Registry Mumber 890839-31-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,0,8,3 and 9 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 890839-31:
(8*8)+(7*9)+(6*0)+(5*8)+(4*3)+(3*9)+(2*3)+(1*1)=213
213 % 10 = 3
So 890839-31-3 is a valid CAS Registry Number.
890839-31-3Relevant academic research and scientific papers
1H-PYRROLO[2,3-B]PYRIDINES
-
Page/Page column 31, (2008/06/13)
Derivatives of pyrrolo[2,3-b]pyridine which are useful as SGK-1 kinase inhibitors are described herein. The invention described herein also describes pharmaceutical compositions containing derivatives of pyrrolo[2,3-b]pyridine and methods of using pyrrolo[2,3-b]pyridine derivatives and pharmaceutical compositions thereof in the treatment of diseases mediated by SGK-1.
